NANOVEU LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.018 AUD | -10.00% |
|
-14.29% | -21.74% |
| 06-04 | Nanoveu Raises AU$2.3 Million for Product Enhancement, Market Expansion; Shares Down 13% | MT |
| 05-30 | Nanoveu Signs Exclusive Distribution Agreement with Rahum Nanotech; Shares Surge 59% | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 10.87 | 6.892 | 9.889 | 6.481 | 2.527 | 9.236 |
| Enterprise Value (EV) 1 | 6.028 | 4.74 | 8.756 | 4.468 | 2.279 | 9.388 |
| P/E ratio | -4.98 x | -2.04 x | -4.98 x | -2.32 x | -0.77 x | -4 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 522 x | 113 x | 26.9 x | 8.3 x | 15.8 x | 90.1 x |
| EV / Revenue | 290 x | 77.7 x | 23.8 x | 5.72 x | 14.3 x | 91.6 x |
| EV / EBITDA | -3.93 x | -1.49 x | -5.25 x | -2.34 x | -0.98 x | -4.47 x |
| EV / FCF | -7.99 x | -3.19 x | -6.98 x | -5.49 x | -1.46 x | -6.18 x |
| FCF Yield | -12.5% | -31.4% | -14.3% | -18.2% | -68.6% | -16.2% |
| Price to Book | 2.1 x | 3.48 x | 8.15 x | 4.09 x | -9.25 x | -84.6 x |
| Nbr of stocks (in thousands) | 132,530 | 132,530 | 152,139 | 209,071 | 280,770 | 401,578 |
| Reference price 2 | 0.0820 | 0.0520 | 0.0650 | 0.0310 | 0.009000 | 0.0230 |
| Announcement Date | 2/28/19 | 3/1/20 | 2/25/21 | 2/28/22 | 2/28/23 | 4/3/24 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0208 | 0.061 | 0.3679 | 0.7812 | 0.1595 | 0.1025 |
| EBITDA 1 | -1.535 | -3.189 | -1.669 | -1.906 | -2.334 | -2.1 |
| EBIT 1 | -1.595 | -3.265 | -1.718 | -1.957 | -2.379 | -2.145 |
| Operating Margin | -7,665.5% | -5,350.57% | -467.04% | -250.47% | -1,491.67% | -2,092.18% |
| Earnings before Tax (EBT) 1 | -1.568 | -3.373 | -1.762 | -2.321 | -2.707 | -2.16 |
| Net income 1 | -1.568 | -3.373 | -1.762 | -2.321 | -2.707 | -2.16 |
| Net margin | -7,537.05% | -5,527.45% | -479% | -297.05% | -1,697.24% | -2,106.47% |
| EPS 2 | -0.0164 | -0.0254 | -0.0131 | -0.0134 | -0.0118 | -0.005754 |
| Free Cash Flow 1 | -0.7544 | -1.486 | -1.254 | -0.8134 | -1.563 | -1.52 |
| FCF margin | -3,625.77% | -2,435.7% | -341.03% | -104.12% | -979.78% | -1,482.21% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/28/19 | 3/1/20 | 2/25/21 | 2/28/22 | 2/28/23 | 4/3/24 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 0.15 |
| Net Cash position 1 | 4.84 | 2.15 | 1.13 | 2.01 | 0.25 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -0.0725 x |
| Free Cash Flow 1 | -0.75 | -1.49 | -1.25 | -0.81 | -1.56 | -1.52 |
| ROE (net income / shareholders' equity) | -57.3% | -94.1% | -110% | -166% | -413% | 1,771% |
| ROA (Net income/ Total Assets) | -34.3% | -50.9% | -49.4% | -53.8% | -93.5% | -282% |
| Assets 1 | 4.569 | 6.622 | 3.567 | 4.313 | 2.895 | 0.7646 |
| Book Value Per Share 2 | 0.0400 | 0.0100 | 0.0100 | 0.0100 | -0 | -0 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0100 | 0 | 0 |
| Capex 1 | 0.05 | 0.09 | 0.02 | - | - | - |
| Capex / Sales | 250.95% | 141.54% | 5.68% | - | - | - |
| Announcement Date | 2/28/19 | 3/1/20 | 2/25/21 | 2/28/22 | 2/28/23 | 4/3/24 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.74% | 6.7M | |
| +21.59% | 68.87B | |
| -4.38% | 46.12B | |
| +26.09% | 44.85B | |
| +32.63% | 27.9B | |
| +9.25% | 19.38B | |
| +17.22% | 17.2B | |
| -13.50% | 14.68B | |
| -28.13% | 14.14B | |
| -33.19% | 11.49B |
- Stock Market
- Equities
- NVU Stock
- Financials Nanoveu Limited
